secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001213900-24-102170
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix shareholders approve stock plan amendment increasing authorized shares; all director nominees elected
--------------------------------------------------------------------------------

- Plan amendment to increase share authorization under 2019 Omnibus Stock Incentive Plan approved with 16.5M FOR, 2.8M AGAINST, 0.8M abstain.
- All 7 director nominees elected: Dillione, Duncan, Dunton, Kaplan, Lefkowitz, Stewart, Todisco – each received >15.8M FOR votes.
- Non-binding advisory vote on 2023 executive compensation passed (FOR: 17.5M, AGAINST: 2.4M).
- Ratification of Marcum LLP as auditor for FY2024 approved with 40.5M FOR, 215K against, 370K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390024102170/0001213900-24-102170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390024102170/ea0222389-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-102170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer